As if there weren't enough reasons to buy shares of the cardiometabolic drug juggernauts Eli Lilly (LLY 0.74%) and Novo Nordisk (NVO -0.28%), there's now one more big reason to ex ...
Novo Nordisk has asked the FDA to add semaglutide to a list that would effectively block manufacturing of copycat versions of ...
Eli Lilly (LLY) stock drops hurting its rival Novo Nordisk (NVO) after the U.S. drugmaker missed forecasts with Q3 financials and weight loss drugs. Read more here.
Novo Nordisk A/S has fallen behind Eli Lilly & Co. this year in the race to be the big stock market winner from obesity drugs ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Novo Nordisk faces competition from Eli Lilly in new therapeutic areas. Read why I rate NONOF stock as a hold.